GeneDx Holdings share price logo

GeneDx Holdings

NASDAQ: WGS

Mid Cap

$56.15

-10.99

(-16.37%)

as on

GeneDx Holdings Stock Performance

as on October 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $55.15
    $67.38
    downward going graph

    1.78%

    Downside

    20.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $32.21
    $170.87
    downward going graph

    42.64%

    Downside

    204.31%

    Upside

    downward going graph

GeneDx Holdings share price movements today

Previous Close
$67.14
Open
$67.16
Volume
2.6M
Market Cap
$2.0B
Day's Low - High
$55.15 - $67.38
52 Week Low - High
$32.21 - $170.87

GeneDx Holdings Historical Returns

1 Month Return
-36.54 %
3 Month Return
-4.99 %
1 Year Return
-56.43 %
3 Year Return
+ 1660.19 %
5 Year Return
0 %

GeneDx Holdings Stock Fundamentals & Key Indicators

Check GeneDx Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-3.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.45

Industry PE ratio

52.77

PEG Ratio

-0.01

EBITDA

-76.4M

Revenue (TTM)

454.4M

Profit Margin

68.20%

Return On Equity TTM

-38.72%

GeneDx Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GeneDx Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
GeneDx Holdings image
GeneDx Holdings
StrongBuy$2.0BNA-18.4568.20%0.00%
Natera image
Natera
StrongBuy$57.9B251.47%-295.1265.30%0.00%
Agilent image
Agilent
StrongBuy$48.8B9.56%34.1753.73%0.57%
Thermo Fisher image
Thermo Fisher
StrongBuy$254.2B10.11%35.6341.44%0.27%
Danaher image
Danaher
StrongBuy$157.6B-26.45%37.5458.59%0.65%

Stock Returns calculator for GeneDx Holdings Stock including INR - Dollar returns

The GeneDx Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

GeneDx Holdings investment value today

Current value as on today

₹47,095

Returns

-₹52,905

(-52.91%)

Returns from GeneDx Holdings Stock

-₹56,429 (-56.43%)

Dollar Impact

₹3,524 (+3.52%)

Analyst Recommendation on GeneDx Holdings Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for GeneDx Holdings. Average target price of $93.5

GeneDx Holdings Share Price Target

Get share price movements and forecasts by analysts on GeneDx Holdings.

What analysts predicted

39.95%UPSIDE

Target Price

$93.5

Current Price

$56.15

Analyzed by

5 Analysts

High

$103

Target

$93.50

Low

$63

GeneDx Holdings target price $93.5, a slight upside of 39.95% compared to current price of $56.15. According to 5 analysts rating.

Indian Investors' Interest in GeneDx Holdings Stock

Search interest for GeneDx Holdings Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

GeneDx Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
62
70
76
95
87
102
116
120
102
114
Gross Profit
37
42
47
66
58
70
84
78
68
78
Operating Income
-13
-10
-7
8
-4
8
-3
-13
-26
-17
EBITDA
-14
-23
-1
11
0
17
0
-10
-54
-10
Interest Expense
0
0
0
0
0
0
0
0
0
1
Depreciation
5
5
5
5
5
6
6
6
6
6
Income Before Tax
-20
-29
-8
5
-6
10
-7
-18
-62
-18
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-20
-29
-8
5
-6
10
-7
-17
-63
-17
Net Profit Margin
59.93%
60.91%
62.22%
69.22%
67.13%
69.04%
72.40%
65.23%
66.71%
68.37%

GeneDx Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
179
212
234
202
305
427
Gross Profit
4
-16
-26
90
194
298
Operating Income
-241
-446
-667
-180
-23
-11
EBITDA
-227
-220
-398
-136
-27
6
Interest Expense
2
2
3
-
3
2
Depreciation
11
21
59
33
21
25
Income Before Tax
-241
-245
-598
-176
-52
-21
Income Tax Expense
-
-
-49
0
0
0
Net Income
-241
-245
-548
-175
-52
-21
Net Profit Margin
2.25%
-7.82%
-11.40%
44.43%
63.64%
69.74%

GeneDx Holdings Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-20
-29
-8
5
-6
10
-7
-17
-63
-17
Operating Cash Flow
-16
-4
-4
-3
10
10
15
-3
-32
-28
Investing Cash Flow
0
-22
-7
0
-9
-36
-4
-11
-17
-5
Financing Cash Flow
0
0
13
31
13
0
10
23
38
1
Change in Cash
-16
-27
1
27
14
-25
21
9
-11
-33

GeneDx Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-241
-245
-548
-175
-52
-21
Operating Cash Flow
-93
-190
-319
-180
-28
33
Investing Cash Flow
-31
-20
-141
-43
-30
-61
Financing Cash Flow
129
493
197
186
44
48
Change in Cash
3
282
-263
-37
-14
19

Global Institutional Holdings in GeneDx Holdings

Check out the Institutions with significant holdings in GeneDx Holdings.

Funds
Holdings
Keith Meister
16.04%
Cathie Wood
5.40%
ARK
4.96%
Vanguard
3.76%
Peter Durbin
2.97%
See all

GeneDx Holdings News & Key Events

  • img

    Today's Timeline - 20 October

    Tue, 06:10 PM

    -

    GeneDx plans to enhance genome testing with long-read whole genome sequencing to improve diagnostic value for patients.

Insights on GeneDx Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -63.31M → -17.74M (in $), with an average increase of 256.9% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, WGS has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 102.25M → 114.43M (in $), with an average increase of 10.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, WGS stock has moved up by 1753.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Natera, Inc. Common Stock has given 109.8% return, outperforming this stock by 166.2%

About GeneDx Holdings

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
OrganisationGeneDx Holdings
HeadquartersNorth Tower, Stamford, CT, 06902, US
IndustryMedical - Diagnostics & Research
CEOKatherine A. Stueland

Key Management of GeneDx Holdings

Name

Title

Mr. Kevin Feeley CPA

Chief Financial Officer

Dr. Bryan M. Dechairo Ph.D.

Chief Technology & Innovation Officer

Mr. Mark A. Gardner M.B.A.

President

Ms. Sabrina V. Dunbar

Director of Investor Relations & Communications

Ms. Heidi C. Chen J.D.

Chief Legal Officer

Ms. Melanie Duquette

Chief Growth Officer

Ms. Katherine A. Stueland

CEO & Director

Ms. Jami Biliboaca

Chief People Officer

Ms. Lisa Gurry

Chief Business Officer

Ms. Linda Genen M.D., M.P.H.

Chief Medical Officer

FAQs

What is GeneDx Holdings share price today?

GeneDx Holdings share price today is $56.15 as on at the close of the market. GeneDx Holdings share today touched a day high of $67.38 and a low of $55.15.

What is the 52 week high and 52 week low for GeneDx Holdings share?

GeneDx Holdings share touched a 52 week high of $170.87 on and a 52 week low of $32.21 on . GeneDx Holdings stock price today i.e. is closed at $56.15,which is 67.14% down from its 52 week high and 74.32% up from its 52 week low.

What is GeneDx Holdings's market capitalisation today?

GeneDx Holdings market capitalisation is $0.00T as on .

How to invest in GeneDx Holdings Stock (WGS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GeneDx Holdings on INDmoney app. Click on Buy button.

What is the minimum amount required to buy GeneDx Holdings Stock (WGS) from India?

Indian investors can start investing in GeneDx Holdings (WGS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in GeneDx Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on GeneDx Holdings share’s latest price of $56.15 as on October 24, 2026 at 8:46 am IST, you will get 0.1781 shares of GeneDx Holdings. Learn more about fractional shares .